Investor Confidence in CryoPort (CYRX) Strengthened Backed by Pipeline Expansion
Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Cryoport Inc. (CYRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | First Eagle Investment Management Jean-Marie Eveillard | 1,268,924 | $22,079,278 | -1% | 0.03% |
| 2. | Roubaix Capital Christopher Hillary | 454,926 | $7,915,712 | +13% | 3.13% |
| 3. | Royce & Associates Chuck Royce | 406,509 | $7,073,257 | 0.06% | |
| 4. | Squarepoint Ops LLC Maxime Fortin (Cio) | 351,201 | $6,110,897 | -5% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.00 | 3,356 | $46,984.00 | 317,265 | 2019-11-12 | Filing | |
| $1.99 | 1,000 | $1,985.00 | 816,494 | 2016-08-26 | Filing | |
| $1.95 | 1,000 | $1,950.00 | 1,000 | 2016-08-19 | Filing | |
| $1.91 | 2,000 | $3,820.00 | 815,494 | 2016-08-18 | Filing | |
| $1.87 | 5,000 | $9,350.00 | 813,494 | 2016-08-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.91 | 28,800 | $429,384.96 | 1,201,814 | 2026-08-11 | Filing | |
| $14.47 | 33,600 | $486,239.04 | 109,719 | 2026-06-11 | Filing | |
| $15.23 | 1,400 | $21,323.96 | 109,719 | 2026-06-10 | Filing | |
| $16.27 | 169,427 | $2,756,983.91 | 109,850 | 2026-06-04 | Filing | |
| $15.44 | 23,214 | $358,452.02 | 67,894 | 2026-06-08 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,415,150 | $24,629,469 | 0% | |
| 2. | 1,026,223 | $17,855,880 | 0% | |
| 3. | 929,481 | $16,172,969 | 0.02% | |
| 4. | 744,891 | $12,961,103 | 0% | |
| 5. | 601,919 | $10,473,391 | 1.99% |
News See All
Cryoport, Inc. (NASDAQ:CYRX) Q1 2026 Earnings Call Transcript
Cryoport, Inc. (NASDAQ:CYRX) Q1 2026 Earnings Call Transcript May 4, 2026Cryoport, Inc. misses on earnings expectations. Reported EPS is $-0.25 EPS, expectations were $-0.2.
Cryoport, Inc. (NASDAQ:CYRX) Q4 2025 Earnings Call Transcript
Cryoport, Inc. (NASDAQ:CYRX) Q4 2025 Earnings Call Transcript March 3, 2026Cryoport, Inc. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.19.
Cryoport, Inc. (NASDAQ:CYRX) Q3 2025 Earnings Call Transcript
Cryoport, Inc. (NASDAQ:CYRX) Q3 2025 Earnings Call Transcript November 4, 2025Cryoport, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23.
Cryoport, Inc. (NASDAQ:CYRX) Q2 2025 Earnings Call Transcript
Cryoport, Inc. (NASDAQ:CYRX) Q2 2025 Earnings Call Transcript August 5, 2025Cryoport, Inc. misses on earnings expectations. Reported EPS is $-0.29 EPS, expectations were $-0.2.
Cryoport, Inc. (NASDAQ:CYRX) Q1 2025 Earnings Call Transcript
Cryoport, Inc. (NASDAQ:CYRX) Q1 2025 Earnings Call Transcript May 7, 2025Cryoport, Inc. misses on earnings expectations. Reported EPS is $-0.28 EPS, expectations were $-0.23.
10 Pump and Dump Stocks Favored by Hedge Funds
In this article, we will take a detailed look at 10 Pump and Dump Stocks Favored by Hedge Funds.
Cryoport, Inc. (NASDAQ:CYRX) Q4 2024 Earnings Call Transcript
Cryoport, Inc. (NASDAQ:CYRX) Q4 2024 Earnings Call Transcript March 4, 2025Cryoport, Inc. misses on earnings expectations. Reported EPS is $-0.42 EPS, expectations were $-0.33.
Cryoport, Inc. (NASDAQ:CYRX) Q3 2024 Earnings Call Transcript
Cryoport, Inc. (NASDAQ:CYRX) Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good afternoon and welcome to the Cryoport Second Quarter 2024 Earnings Call.
Should You Hold Cryoport (CYRX)?
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” second quarter 2024 investor letter.